 | 5NA | Name: | 2-hydroxy-5-methyl naphthoic acid | Formula: | C12 H10 O3 | SMILES: | O=C(O)c1c2c(ccc1O)c(ccc2)C | InChi: | InChI=1S/C12H10O3/c1-7-3-2-4-9-8(7)5-6-10(13)11(9)12(14)15/h2-6,13H,1H3,(H,14,15) | Synonyms: | 2-hydroxy-5-methylnaphthalene-1-carboxylic acid | Definition date: | 2009-07-10 | Last modified: | 2020-06-17 | Identifier: | 2-hydroxy-5-methylnaphthalene-1-carboxylic acid |
|
 | 817 | Name: | 1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE | Formula: | C10 H11 F3 N4 S | SMILES: | FC(F)(F)c1cccc(c1)CSC(=[N@H])NC(=[N@H])N | InChi: | InChI=1S/C10H11F3N4S/c11-10(12,13)7-3-1-2-6(4-7)5-18-9(16)17-8(14)15/h1-4H,5H2,(H5,14,15,16,17) | Synonyms: | 3-(TRIFLUOROMETHYL)BENZYL N-[(E)-AMINO(IMINO)METHYL]IMIDOTHIOCARBAMATE | Definition date: | 2005-08-29 | Last modified: | 2020-06-17 | Identifier: | 3-(trifluoromethyl)benzyl N-carbamimidoylimidothiocarbamate |
|
 | 5NK | Name: | 2-[[2-[[1-(2-azanylethyl)piperidin-4-yl]amino]-4-methyl-benzimidazol-1-yl]methyl]-6-methyl-pyridin-3-ol | Formula: | C22 H30 N6 O | SMILES: | Cc1ccc(O)c(Cn2c(NC3CCN(CCN)CC3)nc4c(C)cccc24)n1 | InChi: | InChI=1S/C22H30N6O/c1-15-4-3-5-19-21(15)26-22(25-17-8-11-27(12-9-17)13-10-23)28(19)14-18-20(29)7-6-16(2)24-18/h3-7,17,29H,8-14,23H2,1-2H3,(H,25,26) | Synonyms: | JNJ-2408068 | Definition date: | 2015-10-27 | Last modified: | 2020-06-17 | Release date: | 2015-12-09 | Identifier: | 2-[[2-[[1-(2-azanylethyl)piperidin-4-yl]amino]-4-methyl-benzimidazol-1-yl]methyl]-6-methyl-pyridin-3-ol |
|
 | 818 | Name: | 18-HYDROXYASCOMYCIN | Formula: | C43 H69 N O13 | SMILES: | O=C3C(=O)N1CCCCC1C(=O)OC(C(=C/C2CCC(O)C(OC)C2)/C)C(C)C(O)CC(=O)C(C=C(C(O)C(CC(OC)C4OC3(O)C(C)CC4OC)C)C)CC | InChi: | InChI=1S/C43H69NO13/c1-10-29-18-23(2)37(48)24(3)19-35(54-8)39-36(55-9)20-26(5)43(52,57-39)40(49)41(50)44-16-12-11-13-30(44)42(51)56-38(27(6)32(46)22-33(29)47)25(4)17-28-14-15-31(45)34(21-28)53-7/h17-18,24,26-32,34-39,45-46,48,52H,10-16,19-22H2,1-9H3/b23-18+,25-17+/t24-,26-,27-,28+,29-,30+,31-,32+,34-,35+,36+,37-,38-,39-,43-/m1/s1 | Synonyms: | L-685,818 | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | (3S,4R,5S,8R,9E,11S,12R,14S,15R,16S,18R,19R,26aS)-8-ethyl-5,11,19-trihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone |
|
 | 5NP | Name: | (9~{b}~{R})-9~{b}-(4-chlorophenyl)-1-pyridin-3-ylcarbonyl-2,3-dihydroimidazo[5,6]pyrrolo[1,2-~{a}]pyridin-5-one | Formula: | C21 H15 Cl N4 O2 | SMILES: | Clc1ccc(cc1)[C]23N(CCN2C(=O)c4ccncc34)C(=O)c5cccnc5 | InChi: | InChI=1S/C21H15ClN4O2/c22-16-5-3-15(4-6-16)21-18-13-24-9-7-17(18)20(28)26(21)11-10-25(21)19(27)14-2-1-8-23-12-14/h1-9,12-13H,10-11H2/t21-/m0/s1 | Synonyms: | BTA-9881 | Definition date: | 2015-10-27 | Last modified: | 2020-06-17 | Release date: | 2015-12-09 | Identifier: | (9~{b}~{R})-9~{b}-(4-chlorophenyl)-1-pyridin-3-ylcarbonyl-2,3-dihydroimidazo[5,6]pyrrolo[1,2-~{a}]pyridin-5-one |
|
 | 5OD | Name: | 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine | Formula: | C16 H19 Cl2 N5 | SMILES: | CC1(N)CCN(CC1)c2cnc(c(N)n2)c3cccc(Cl)c3Cl | InChi: | InChI=1S/C16H19Cl2N5/c1-16(20)5-7-23(8-6-16)12-9-21-14(15(19)22-12)10-3-2-4-11(17)13(10)18/h2-4,9H,5-8,20H2,1H3,(H2,19,22) | Synonyms: | SHP099 | Definition date: | 2015-10-29 | Last modified: | 2020-06-17 | Release date: | 2016-06-29 | Identifier: | 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine |
|
 | 822 | Name: | N-ACETYL-N-[1-(1,1'-BIPHENYL-4-YLMETHYL)-2-OXOAZEPAN-3-YL]-4-[DIFLUORO(PHOSPHONO)METHYL]PHENYLALANINAMIDE | Formula: | C31 H34 F2 N3 O6 P | SMILES: | FC(F)(c1ccc(cc1)CC(NC(=O)C)C(=O)NC4C(=O)N(Cc3ccc(c2ccccc2)cc3)CCCC4)P(=O)(O)O | InChi: | InChI=1S/C31H34F2N3O6P/c1-21(37)34-28(19-22-12-16-26(17-13-22)31(32,33)43(40,41)42)29(38)35-27-9-5-6-18-36(30(27)39)20-23-10-14-25(15-11-23)24-7-3-2-4-8-24/h2-4,7-8,10-17,27-28H,5-6,9,18-20H2,1H3,(H,34,37)(H,35,38)(H2,40,41,42)/t27-,28-/m0/s1 | Synonyms: | RU82209 | Definition date: | 2003-06-20 | Last modified: | 2020-06-17 | Identifier: | Nalpha-acetyl-N-[(3S)-1-(biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]-4-[difluoro(phosphono)methyl]-L-phenylalaninamide |
|
 | 5OP | Name: | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID | Formula: | C20 H30 O5 | SMILES: | O=C(O)CCC/C=C/CC1C(=O)CC(O)C1C=CC(=O)CCCCC | InChi: | InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,16-17,19,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4?,13-12+ | Synonyms: | 15-OXO-PGE2 | Definition date: | 2003-11-11 | Last modified: | 2020-06-17 | Identifier: | (8beta,13E)-11-hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid |
|
 | 5OY | Name: | 5-phosphono-L-norvaline | Formula: | C5 H12 N O5 P | SMILES: | N[CH](CCC[P](O)(O)=O)C(O)=O | InChi: | InChI=1S/C5H12NO5P/c6-4(5(7)8)2-1-3-12(9,10)11/h4H,1-3,6H2,(H,7,8)(H2,9,10,11)/t4-/m0/s1 | Synonyms: | (2~{S})-2-azanyl-5-phosphono-pentanoic acid | Definition date: | 2015-11-02 | Last modified: | 2020-06-17 | Release date: | 2016-11-09 | Identifier: | (2~{S})-2-azanyl-5-phosphono-pentanoic acid |
|
 | 5OZ | Name: | 2-methylpropanal | Formula: | C4 H8 O | SMILES: | CC(C)C=O | InChi: | InChI=1S/C4H8O/c1-4(2)3-5/h3-4H,1-2H3 | Synonyms: | Isobutyraldehyde | Definition date: | 2015-11-03 | Last modified: | 2020-06-17 | Release date: | 2016-11-16 | Identifier: | 2-methylpropanal |
|
 | 5PA | Name: | N-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-Y-LMETHYL]-1-AMINO-CYCLOPROPANECARBOXYLIC ACID | Formula: | C12 H17 N2 O7 P | SMILES: | O=C(O)C2(NCc1c(cnc(c1O)C)COP(=O)(O)O)CC2 | InChi: | InChI=1S/C12H17N2O7P/c1-7-10(15)9(5-14-12(2-3-12)11(16)17)8(4-13-7)6-21-22(18,19)20/h4,14-15H,2-3,5-6H2,1H3,(H,16,17)(H2,18,19,20) | Synonyms: | N-PYRIDOXYL-1-AMINO-CYCLOPROPANECARBOXYLIC ACID-5-MONOPHOSPHATE | Definition date: | 1999-10-21 | Last modified: | 2020-06-17 | Identifier: | 1-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]cyclopropanecarboxylic acid |
|
 | 5PI | Name: | N-(ETHYLSULFONYL)-5-PROPOXY-L-TRYPTOPHYL-N~1~-{4-[AMINO(IMINO)METHYL]BENZYL}-L-GLUTAMAMIDE | Formula: | C29 H39 N7 O6 S | SMILES: | O=C(NCc1ccc(C(=[N@H])N)cc1)C(NC(=O)C(NS(=O)(=O)CC)Cc3c2cc(OCCC)ccc2nc3)CCC(=O)N | InChi: | InChI=1S/C29H39N7O6S/c1-3-13-42-21-9-10-23-22(15-21)20(17-33-23)14-25(36-43(40,41)4-2)29(39)35-24(11-12-26(30)37)28(38)34-16-18-5-7-19(8-6-18)27(31)32/h5-10,15,17,24-25,33,36H,3-4,11-14,16H2,1-2H3,(H2,30,37)(H3,31,32)(H,34,38)(H,35,39)/t24-,25+/m0/s1 | Synonyms: | 2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE
1-(4-CARBAMIMIDOYL-BENZYLAMIDE) | Definition date: | 2004-12-17 | Last modified: | 2020-06-17 | Identifier: | N-(ethylsulfonyl)-5-propoxy-D-tryptophyl-N~1~-(4-carbamimidoylbenzyl)-L-glutamamide |
|
 | 83A | Name: | N-(4-{[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)ethyl]amino}benzene-1-carbonyl)-L-glutamic acid | Formula: | C20 H22 N6 O6 | SMILES: | c31c(N=C(NC1=O)N)nc(CCNc2ccc(C(=O)NC(C(=O)O)CCC(O)=O)cc2)c3 | InChi: | InChI=1S/C20H22N6O6/c21-20-25-16-13(18(30)26-20)9-12(23-16)7-8-22-11-3-1-10(2-4-11)17(29)24-14(19(31)32)5-6-15(27)28/h1-4,9,14,22H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,21,23,25,26,30)/t14-/m0/s1 | Synonyms: | antifolate AGF183 | Definition date: | 2016-03-28 | Last modified: | 2020-06-17 | Release date: | 2016-08-10 | Identifier: | N-(4-{[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)ethyl]amino}benzene-1-carbonyl)-L-glutamic acid |
|
 | 5PM | Name: | 4,4'-sulfanediylbis{N-[(1E)-pyridin-2-ylmethylidene]aniline} | Formula: | C24 H18 N4 S | SMILES: | N(/c3ccc(Sc2ccc(/N=C/c1ncccc1)cc2)cc3)=Cc4ncccc4 | InChi: | InChI=1S/C24H18N4S/c1-3-15-25-21(5-1)17-27-19-7-11-23(12-8-19)29-24-13-9-20(10-14-24)28-18-22-6-2-4-16-26-22/h1-18H/b27-17+,28-18+ | Synonyms: | 1,1-Bis(N-(4-phenyl)-2-pyridylcarboxaldimine)thioether | Definition date: | 2009-03-17 | Last modified: | 2020-06-17 | Identifier: | 4,4'-sulfanediylbis{N-[(1E)-pyridin-2-ylmethylidene]aniline} |
|
 | 83H | Name: | 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one | Formula: | C21 H24 N4 O | SMILES: | O=C3N(c2cc1c5c(nc1cc2C3(C)C)c4nnc(c4CCC5)C)CC | InChi: | InChI=1S/C21H24N4O/c1-5-25-17-9-14-13-8-6-7-12-11(2)23-24-19(12)18(13)22-16(14)10-15(17)21(3,4)20(25)26/h9-10,22H,5-8H2,1-4H3,(H,23,24) | Synonyms: | 8-Ethyl-2,5,6,12-tetrahydro-3,10,10-trimethyl-9-oxo-pyrazolo[4'3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indole | Definition date: | 2008-04-02 | Last modified: | 2020-06-17 | Identifier: | 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one |
|
 | 5PX | Name: | 4-Cyclopropyl-3,4-dihydro-7-hydroxy-2H-1,2,4-benzothiadiazine 1,1-dioxide | Formula: | C10 H12 N2 O3 S | SMILES: | Oc1ccc2N(CN[S](=O)(=O)c2c1)C3CC3 | InChi: | InChI=1S/C10H12N2O3S/c13-8-3-4-9-10(5-8)16(14,15)11-6-12(9)7-1-2-7/h3-5,7,11,13H,1-2,6H2 | Synonyms: | BPAM-521 | Definition date: | 2015-11-05 | Last modified: | 2020-06-17 | Release date: | 2016-05-04 | Identifier: | 4-cyclopropyl-1,1-bis(oxidanylidene)-2,3-dihydro-1$l^{6},2,4-benzothiadiazin-7-ol |
|
 | 840 | Name: | Platensimycin A1 | Formula: | C24 H25 N O8 | SMILES: | O=C(O)c1c(O)c(c(O)cc1)NC(=O)CCC5(C(=O)C=CC43CC26C(OC2(C3O)C)(C45)C6)C | InChi: | InChI=1S/C24H25NO8/c1-20(7-6-14(28)25-15-12(26)4-3-11(16(15)29)17(30)31)13(27)5-8-22-9-23-10-24(23,18(20)22)33-21(23,2)19(22)32/h3-5,8,18-19,26,29,32H,6-7,9-10H2,1-2H3,(H,25,28)(H,30,31)/t18-,19+,20-,21+,22-,23+,24-/m1/s1 | Synonyms: | 2,4-dihydroxy-3-({3-[(1aR,2R,3R,3aS,7S,7aS,7bR)-3-hydroxy-2,7-dimethyl-6-oxo-2,3,7,7a-tetrahydro-6H-2,7b-epoxy-1a,3a-me
thanocyclopropa[a]naphthalen-7(1H)-yl]propanoyl}amino)benzoic acid | Definition date: | 2009-07-10 | Last modified: | 2020-06-17 | Identifier: | 2,4-dihydroxy-3-({3-[(1aR,2R,3R,3aS,7S,7aS,7bR)-3-hydroxy-2,7-dimethyl-6-oxo-2,3,7,7a-tetrahydro-6H-2,7b-epoxy-1a,3a-methanocyclopropa[a]naphthalen-7(1H)-yl]propanoyl}amino)benzoic acid |
|
 | 846 | Name: | [4R--(1ALPHA,5ALPHA,7BETA)]-3-[(CYCLOPROPHYLMETHYL)HEXAHYDRO-5,6-DIHYDROXY-2-OXO-4,7-BIS(PHENYLMETHYL)-1H-1,3-DIAZEPIN]
METHYL-2-THIAZOLYLBENZAMIDE | Formula: | C34 H36 N4 O4 S | SMILES: | O=C(c1cccc(c1)CN4C(=O)N(CC2CC2)C(Cc3ccccc3)C(O)C(O)C4Cc5ccccc5)Nc6nccs6 | InChi: | InChI=1S/C34H36N4O4S/c39-30-28(19-23-8-3-1-4-9-23)37(21-25-14-15-25)34(42)38(29(31(30)40)20-24-10-5-2-6-11-24)22-26-12-7-13-27(18-26)32(41)36-33-35-16-17-43-33/h1-13,16-18,25,28-31,39-40H,14-15,19-22H2,(H,35,36,41)/t28-,29-,30+,31+/m1/s1 | Synonyms: | INHIBITOR Q8467 OF DUPONT MERCK | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 3-{[(4R,5S,6S,7R)-4,7-dibenzyl-3-(cyclopropylmethyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}-N-1,3-thiazol-2-ylbenzamide |
|
 | 847 | Name: | 2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE | Formula: | C18 H13 Br N4 O5 | SMILES: | [O-]C(=O)CC(C([O-])=O)c3cc(c2nc1cc(ccc1n2)C(=[NH2+])N)c([O-])c(Br)c3 | InChi: | InChI=1S/C18H15BrN4O5/c19-11-4-8(9(18(27)28)6-14(24)25)3-10(15(11)26)17-22-12-2-1-7(16(20)21)5-13(12)23-17/h1-5,9,26H,6H2,(H3,20,21)(H,22,23)(H,24,25)(H,27,28)/p-2/t9-/m1/s1 | Synonyms: | CRA_16847 | Definition date: | 2003-03-14 | Last modified: | 2020-06-17 | Identifier: | (2R)-2-(3-{5-[amino(iminio)methyl]-1H-benzimidazol-2-yl}-5-bromo-4-oxidophenyl)butanedioate |
|
 | 853 | Name: | 5-[2-ACETYLAMINO-2-(1-BIPHENYL-4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)-ETHYL]-2-CARBOXYMETHYL-BENZOIC ACID | Formula: | C33 H35 N3 O7 | SMILES: | O=C(O)c1cc(ccc1CC(=O)O)CC(NC(=O)C)C(=O)NC4C(=O)N(Cc3ccc(c2ccccc2)cc3)CCCC4 | InChi: | InChI=1S/C33H35N3O7/c1-21(37)34-29(18-23-12-15-26(19-30(38)39)27(17-23)33(42)43)31(40)35-28-9-5-6-16-36(32(28)41)20-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,17,28-29H,5-6,9,16,18-20H2,1H3,(H,34,37)(H,35,40)(H,38,39)(H,42,43)/t28-,29-/m0/s1 | Synonyms: | RU85053 | Definition date: | 2003-06-20 | Last modified: | 2020-06-17 | Identifier: | 5-[(2S)-2-(acetylamino)-3-{[(3S)-1-(biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]amino}-3-oxopropyl]-2-(carboxymethyl)benzoic acid |
|
 | 85F | Name: | (2R)-2-azanyl-3-[(2R)-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]sulfanyl-propanoic acid | Formula: | C6 H12 N2 O4 S | SMILES: | N[CH](CSC[CH](N)C(O)=O)C(O)=O | InChi: | InChI=1S/C6H12N2O4S/c7-3(5(9)10)1-13-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1 | Synonyms: | L-Lanthionine | Definition date: | 2017-04-20 | Last modified: | 2020-06-17 | Release date: | 2018-04-11 | Identifier: | (2~{R})-2-azanyl-3-[(2~{R})-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]sulfanyl-propanoic acid |
|
 | 5RM | Name: | (5R)-5-(4-methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one | Formula: | C14 H19 N O4 | SMILES: | CCCOc1cc(ccc1OC)[C]2(C)CNC(=O)O2 | InChi: | InChI=1S/C14H19NO4/c1-4-7-18-12-8-10(5-6-11(12)17-3)14(2)9-15-13(16)19-14/h5-6,8H,4,7,9H2,1-3H3,(H,15,16)/t14-/m0/s1 | Synonyms: | (R)-MESOPRAM | Definition date: | 2004-11-17 | Last modified: | 2020-06-17 | Identifier: | (5R)-5-(4-methoxy-3-propoxy-phenyl)-5-methyl-1,3-oxazolidin-2-one |
|
 | 5S7 | Name: | (2~{R},3~{R},4~{S},5~{S})-2-[2,6-bis(azanyl)purin-9-yl]-5-(methylsulfanylmethyl)oxolane-3,4-diol | Formula: | C11 H16 N6 O3 S | SMILES: | CSC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)nc(N)nc23 | InChi: | InChI=1S/C11H16N6O3S/c1-21-2-4-6(18)7(19)10(20-4)17-3-14-5-8(12)15-11(13)16-9(5)17/h3-4,6-7,10,18-19H,2H2,1H3,(H4,12,13,15,16)/t4-,6-,7-,10-/m1/s1 | Synonyms: | 2-amino-5'-deoxy-5'-(methylthio)adenosine | Definition date: | 2015-11-19 | Last modified: | 2020-06-17 | Release date: | 2016-12-21 | Identifier: | (2~{R},3~{R},4~{S},5~{S})-2-[2,6-bis(azanyl)purin-9-yl]-5-(methylsulfanylmethyl)oxolane-3,4-diol |
|
 | 869 | Name: | (1-TERT-BUTYL-5-HYDROXY-1H-PYRAZOL-4-YL)[6-(METHYLSULFONYL)-4'-METHOXY-2-METHYL-1,1'-BIPHENYL-3-YL]METHANONE | Formula: | C23 H26 N2 O5 S | SMILES: | O=C(c1c(O)n(nc1)C(C)(C)C)c3ccc(c(c2ccc(OC)cc2)c3C)S(=O)(=O)C | InChi: | InChI=1S/C23H26N2O5S/c1-14-17(21(26)18-13-24-25(22(18)27)23(2,3)4)11-12-19(31(6,28)29)20(14)15-7-9-16(30-5)10-8-15/h7-13,27H,1-6H3 | Synonyms: | (1-TERT-BUTYL-5-HYDROXY-1H-PYRAZOL-4-YL)-(6-METHANESULFONYL-4'-METHOXY-2-METHYL-BIPHENYL-3-YL)-METHANONE | Definition date: | 2004-03-29 | Last modified: | 2020-06-17 | Identifier: | (1-tert-butyl-5-hydroxy-1H-pyrazol-4-yl)[4'-methoxy-2-methyl-6-(methylsulfonyl)biphenyl-3-yl]methanone |
|
 | 86B | Name: | 4-{(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzene-1-sulfonamide | Formula: | C12 H20 N2 O4 S | SMILES: | c1(S(=O)(=O)N)ccc(cc1)OCC(CNC(C)C)O | InChi: | InChI=1S/C12H20N2O4S/c1-9(2)14-7-10(15)8-18-11-3-5-12(6-4-11)19(13,16)17/h3-6,9-10,14-15H,7-8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1 | Synonyms: | aryloxy-2-hydroxypropylammine sulfonamide | Definition date: | 2017-08-02 | Last modified: | 2020-06-17 | Release date: | 2018-08-01 | Identifier: | 4-{(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzene-1-sulfonamide |
|